Innovation Pharmaceuticals Inc. Stock Price - IPIX

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Innovation Pharmaceuticals Inc. (QB) IPIX OTCMarkets Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.0028 5.0% 0.0588 0.062 0.0521 0.062 0.056 16:00:02
Bid Price Ask Price Spread Spread % News
0.051 0.0589 0.0078 13.27% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
47 448,998 $ 0.055952 $ 25,122 418,245 0.05 - 0.4351
Last Trade Time Type Quantity Stock Price Currency
15:58:40 5,000 $ 0.0588 USD

Innovation Pharmaceuticals Inc. Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 12.49M 212.37M $ -16.36M - - 128.46M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
524.08k $ - 0.00% - -

more financials information »

Innovation Pharmaceuticals Inc. News

Loading Messages....

Latest IPIX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IPIX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.0720.09990.05210.06324468,241-0.0132-18.33%
1 Month0.08250.09990.050.0709723657,505-0.0237-28.73%
3 Months0.,773-0.0712-54.77%
6 Months0.2230.240.050.1234837385,935-0.1642-73.63%
1 Year0.140.43510.050.1569063468,354-0.0812-58.0%
3 Years1.171.490.050.3912292349,221-1.11-94.97%
5 Years4.524.930.051.06317,742-4.46-98.7%

Innovation Pharmaceuticals Inc. Description

An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.